Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

TimesSquare Capital Management U.S. Mid Cap Growth Strategy 2026 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (TimesSquare Capital Management U.S. Mid Cap Growth Strategy)

Primary Source Intelligence • Q3 2026 Letter Analysis

TimesSquare Capital Management U.S. Mid Cap Growth Strategy Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, TimesSquare Capital Management U.S. Mid Cap Growth Strategy. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD-5.7%

YTD+2.86%

Annualized+9.14%

Positioning StanceCONSTRUCTIVE

Market CapMid Cap

GeographyUS

Digest Analysis

Quick Take

"Constructive on resilient mid-cap growth leaders exposed to early-stage optical AI infrastructure and enterprise observability, initiating $LITE and $CRDO while exiting $RRX and $IONS amid monetary tightening and multiple compression."

Executive Summary

The TimesSquare U.S. Mid Cap Growth Strategy returned -5.70% net of fees in the third quarter of 2026, outperforming the Russell Midcap Growth Index return of -5.84%. Year-to-date, the strategy has gained 2.86% net of fees compared to 1.01% for the benchmark. Relative outperformance was primarily driven by positive stock selection within Consumer Discretionary (+1.15% active contribution) and Health Care (+0.40%), alongside an underweight in Communication Services (+0.28%). These gains were partially offset by positioning headwinds in Industrials (-0.37%), Financials (-0.36%), and Energy (-0.33%). Cash exposure remained neutral, and the portfolio maintained full equity investment across its diversified sector allocations. Macroeconomic conditions were defined by a Federal Reserve rate hike of 25 basis points to 3.75%-4.00%, rising Treasury yields, and escalating oil prices due to unresolved U.S.-Iran conflict. Despite persistent economic expansion across services and manufacturing, market breadth narrowed substantially, penalizing high-momentum growth assets and heavily favoring companies with lower financial leverage and higher profitability. Key portfolio transactions included trimming top performers Veeva Systems ($VEEV) following substantial price appreciation, and initiating new positions in optical networking supplier Lumentum Holdings ($LITE) and high-speed connectivity provider Credo Technology ($CRDO). Conversely, the strategy completely exited Regal Rexnord ($RRX) to rotate capital into RBC Bearings ($RBC), and liquidated Ionis Pharmaceuticals ($IONS) after two late-stage Phase 3 pipeline setbacks.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

58%

CautiousHigh

Moderate (58%)

Portfolio construction reflects a moderate level of conviction, distributing capital across 60 to 80 holdings with typical individual position weights between 1.0% and 3.0%. Sizing decisions remain disciplined, demonstrated by trimming winning positions like Veeva Systems into strength while swiftly liquidating broken clinical theses such as Ionis Pharmaceuticals.

Growth Outlook

45%

BearishBullish

Neutral (45%)

Management expresses a balanced but cautious outlook in light of the Federal Reserve resuming interest rate hikes, elevated Treasury yields, and renewed oil price shocks. Although macroeconomic indicators in manufacturing and services remain expansive, narrow market breadth and deteriorating consumer sentiment temper overall enthusiasm.

Risk Appetite

48%

DefensiveAggressive

Balanced (48%)

Risk positioning is defensive relative to broad equity momentum, tilting intentionally toward profitable, low-leverage balance sheets while shunning speculative high-beta assets. The strategy accepts lagging during speculative rallies to preserve capital on market down days, deliberately avoiding excessive valuation multiples.

Capital Deployment

50%

De-riskingDeploying

Net Neutral (50%)

Capital deployment operated on a balanced, self-funding footing, funding new mid-cap initiations like Lumentum and Credo Technology through profits taken in Veeva Systems and complete liquidations in Regal Rexnord and Ionis. Net cash allocations remained stable without directional cash hoarding.

Forward Guidance

52%

CautiousExpansionary

Neutral (52%)

Action bias centers on measured, selective capital allocation rather than sweeping portfolio restructuring. The team is re-evaluating whether benchmark weights reflect durable secular themes while actively avoiding aggressive deployment into expensive segments vulnerable to higher borrowing costs.

Language Signal

46%

BearishBullish

Balanced (46%)

Commentary balances favorable secular opportunities in optical networking and enterprise automation with persistent warnings regarding multiple de-ratings, earnings resets, and competitive disruption. Bearish references to failed pharmaceutical programs and commodity shocks offset enthusiasm around artificial intelligence adoption.

Perceived Risk

68%

Low RiskElevated

Elevated Risk (68%)

Macroeconomic and market-level risks receive extensive focus, specifically highlighting the Federal Reserve tightening cycle, geopolitical escalations involving Iran, and higher financing costs. Fundamental risks also include potential AI-driven disintermediation of traditional seat-based software business models.

Opportunity Density

52%

ScarceAbundant

Selective (52%)

The investable universe is viewed through a lens of selectivity rather than abundance, particularly as management warns that the AI spending cycle may narrow its beneficiaries over time. Compelling opportunities remain concentrated in early infrastructure adoption and select industrials rather than broad-based growth assets.

Time Horizon

72%

Short-TermLong-Term

Decade+ (72%)

Investment horizons are anchored across multi-year operational cycles, supported by holdings with revenue booked through 2027 and multi-year product upgrade trajectories. Management specifically notes that single-month benchmark fluctuations will not prompt reactive short-term portfolio turnover.